Patients with AD have been found to have elevated levels of Tumor necrosis factor-α (TNF-α), IL-1β, and other neuroinflammation-related variables (Bagyinszky et al., 2017; Wang et al., 2018). Here, TNF is linked to Alzheimer disease.